[HTML][HTML] Microglia in neuroinflammation and neurodegeneration: from understanding to therapy
L Muzio, A Viotti, G Martino - Frontiers in neuroscience, 2021 - frontiersin.org
Microglia are the resident macrophages of the central nervous system (CNS) acting as the
first line of defense in the brain by phagocytosing harmful pathogens and cellular debris …
first line of defense in the brain by phagocytosing harmful pathogens and cellular debris …
[HTML][HTML] The contribution of microglia to neuroinflammation in Parkinson's disease
K Badanjak, S Fixemer, S Smajić, A Skupin… - International Journal of …, 2021 - mdpi.com
With the world's population ageing, the incidence of Parkinson's disease (PD) is on the rise.
In recent years, inflammatory processes have emerged as prominent contributors to the …
In recent years, inflammatory processes have emerged as prominent contributors to the …
Parkinson's disease: etiology, neuropathology, and pathogenesis
A Kouli, KM Torsney, WL Kuan - Exon Publications, 2018 - exonpublications.com
Parkinson's disease (PD) is a common neurodegenerative disorder. While a number of
nonmotor manifestations arise, the typical clinical features involve a movement disorder …
nonmotor manifestations arise, the typical clinical features involve a movement disorder …
[HTML][HTML] Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells
L Iovino, ME Tremblay, L Civiero - Journal of pharmacological sciences, 2020 - Elsevier
Glutamate is the major excitatory neurotransmitter in the central nervous system. Glutamate
transmission efficiency depends on the correct functionality and expression of a plethora of …
transmission efficiency depends on the correct functionality and expression of a plethora of …
Linking neuroinflammation and neurodegeneration in Parkinson's disease
G Gelders, V Baekelandt… - Journal of immunology …, 2018 - Wiley Online Library
Neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's disease
(AD) impose a pressing burden on our developed and consequently aging society …
(AD) impose a pressing burden on our developed and consequently aging society …
Exosomes as drug delivery vehicles for Parkinson's disease therapy
Exosomes are naturally occurring nanosized vesicles that have attracted considerable
attention as drug delivery vehicles in the past few years. Exosomes are comprised of natural …
attention as drug delivery vehicles in the past few years. Exosomes are comprised of natural …
[HTML][HTML] Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Inflammation occurs as a result of exposure of tissues and organs to harmful stimuli such as
microbial pathogens, irritants, or toxic cellular components. The primary physical …
microbial pathogens, irritants, or toxic cellular components. The primary physical …
[HTML][HTML] Neuroinflammation in Parkinson's disease and its potential as therapeutic target
Q Wang, Y Liu, J Zhou - Translational neurodegeneration, 2015 - Springer
Abstract Parkinson's disease (PD), the second most common age-associated
neurodegenerative disorder, is characterized by the loss of dopaminergic (DA) neurons and …
neurodegenerative disorder, is characterized by the loss of dopaminergic (DA) neurons and …
Microglia in Parkinson's disease
MS Ho - Neuroglia in neurodegenerative diseases, 2019 - Springer
Microglia are the most abundant immune cells in the central nervous system (CNS), where
they interact with neurons and exhibit a wide array of functions in physiological and …
they interact with neurons and exhibit a wide array of functions in physiological and …
[HTML][HTML] Autophagy and apoptosis dysfunction in neurodegenerative disorders
Autophagy and apoptosis are basic physiologic processes contributing to the maintenance
of cellular homeostasis. Autophagy encompasses pathways that target long-lived cytosolic …
of cellular homeostasis. Autophagy encompasses pathways that target long-lived cytosolic …